These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12903863)

  • 41. On the role of Baseline measurements for crossover designs under the self and mixed carryover effects model.
    Liang Y; Carriere KC
    Biometrics; 2010 Mar; 66(1):140-8. PubMed ID: 19432775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonparametric confidence intervals for Tmax in sequence-stratified crossover studies.
    Willavize SA; Morgenthien EA
    Pharm Stat; 2008; 7(1):9-19. PubMed ID: 17256803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of bias-corrected covariance estimators for generalized estimating equations.
    Fan C; Zhang D; Zhang CH
    J Biopharm Stat; 2013; 23(5):1172-87. PubMed ID: 23957522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimating slope and level change in N = 1 designs.
    Solanas A; Manolov R; Onghena P
    Behav Modif; 2010 May; 34(3):195-218. PubMed ID: 20234005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of models for average bioequivalence in replicated crossover designs.
    Willavize SA; Morgenthien EA
    Pharm Stat; 2006; 5(3):201-11. PubMed ID: 17080753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Various varying variances: The challenge of nuisance parameters to the practising biostatistician.
    Senn S
    Stat Methods Med Res; 2015 Aug; 24(4):403-19. PubMed ID: 24492794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An alternative derivation of Harville's restricted log likelihood function for variance component estimation.
    Xu S
    Biom J; 2019 Jan; 61(1):157-161. PubMed ID: 30387166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of the violation of normality and sphericity in the linear mixed model in split-plot designs].
    Arnau J; Bendayan R; Blanca MJ; Bono R
    Psicothema; 2012; 24(3):449-54. PubMed ID: 22748739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hierarchical modelling of variance components makes analysis of resolvable incomplete block designs more efficient.
    Studnicki M; Piepho HP
    Theor Appl Genet; 2024 May; 137(6):134. PubMed ID: 38753078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Point estimation in adaptive enrichment designs.
    Kunzmann K; Benner L; Kieser M
    Stat Med; 2017 Nov; 36(25):3935-3947. PubMed ID: 28783881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating the encounter rate variance in distance sampling.
    Fewster RM; Buckland ST; Burnham KP; Borchers DL; Jupp PE; Laake JL; Thomas L
    Biometrics; 2009 Mar; 65(1):225-36. PubMed ID: 18363772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subject-by-formulation interaction in determinations of individual bioequivalence: bias and prevalence.
    Endrenyi L; Tothfalusi L
    Pharm Res; 1999 Feb; 16(2):186-90. PubMed ID: 10100301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overcoming feelings of powerlessness in "aging" researchers: a primer on statistical power in analysis of variance designs.
    Levin JR
    Psychol Aging; 1997 Mar; 12(1):84-106. PubMed ID: 9100270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matched case-control data analysis with selection bias.
    Lin IF; Paik MC
    Biometrics; 2001 Dec; 57(4):1106-12. PubMed ID: 11764250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Marginal mean weighting through stratification: a generalized method for evaluating multivalued and multiple treatments with nonexperimental data.
    Hong G
    Psychol Methods; 2012 Mar; 17(1):44-60. PubMed ID: 21843003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Quasi-REML" correlation estimates between production and health traits in the presence of selection and confounding: a simulation study.
    Gates P; Johansson K; Danell B
    J Anim Sci; 1999 Mar; 77(3):558-68. PubMed ID: 10229350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. THE MIXED-MODEL ANALYSIS OF VARIANCE APPLIED TO QUANTITATIVE GENETICS: BIOLOGICAL MEANING OF THE PARAMETERS.
    Fry JD
    Evolution; 1992 Apr; 46(2):540-550. PubMed ID: 28564026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.